China Choroidal Neovascularization Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Choroidal neovascularization describes the growth of new blood vessels that originate from the choroid through a break in the Bruch membrane into the sub–retinal pigment epithelium (sub-RPE) or subretinal space.

    This report offers an overview of the market trends, drivers, and barriers with respect to the China Choroidal Neovascularization market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Choroidal Neovascularization market. Detailed analysis of key players, along with key growth strategies adopted by Choroidal Neovascularization industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Pfizer Inc

    • F Hoffmann-La Roche Ltd

    • Promedior Inc

    • Regeneron Pharmaceuticals Inc

    • QLT Inc

    • Sanwa Kagaku Kenkyusho Co Ltd

    • Valeant Pharmaceuticals International Inc

    • Bayer AG

    • Novartis AG

    • Gilead Sciences Inc

    By Type:

    • Intravenous

    • Intravitreal

    By End-User:

    • Extreme Myopia

    • Malignant Myopic Degeneration

    • Age-related Developments

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Choroidal Neovascularization Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Choroidal Neovascularization Market Size and Growth Rate of Intravenous from 2016 to 2027

    • 1.3.2 China Choroidal Neovascularization Market Size and Growth Rate of Intravitreal from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Choroidal Neovascularization Market Size and Growth Rate of Extreme Myopia from 2016 to 2027

    • 1.4.2 China Choroidal Neovascularization Market Size and Growth Rate of Malignant Myopic Degeneration from 2016 to 2027

    • 1.4.3 China Choroidal Neovascularization Market Size and Growth Rate of Age-related Developments from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Choroidal Neovascularization Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Choroidal Neovascularization Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Choroidal Neovascularization Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Choroidal Neovascularization Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Choroidal Neovascularization Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Choroidal Neovascularization Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Choroidal Neovascularization Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Choroidal Neovascularization Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Choroidal Neovascularization by Major Types

    • 3.4.1 Market Size and Growth Rate of Intravenous

    • 3.4.2 Market Size and Growth Rate of Intravitreal

    4 Segmentation of Choroidal Neovascularization Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Choroidal Neovascularization by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Choroidal Neovascularization in Extreme Myopia

    • 4.4.2 Market Size and Growth Rate of Choroidal Neovascularization in Malignant Myopic Degeneration

    • 4.4.3 Market Size and Growth Rate of Choroidal Neovascularization in Age-related Developments

    5 Market Analysis by Regions

    • 5.1 China Choroidal Neovascularization Production Analysis by Regions

    • 5.2 China Choroidal Neovascularization Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Choroidal Neovascularization Landscape Analysis

    • 6.1 North China Choroidal Neovascularization Landscape Analysis by Major Types

    • 6.2 North China Choroidal Neovascularization Landscape Analysis by Major End-Users

    7 Central China Choroidal Neovascularization Landscape Analysis

    • 7.1 Central China Choroidal Neovascularization Landscape Analysis by Major Types

    • 7.2 Central China Choroidal Neovascularization Landscape Analysis by Major End-Users

    8 South China Choroidal Neovascularization Landscape Analysis

    • 8.1 South China Choroidal Neovascularization Landscape Analysis by Major Types

    • 8.2 South China Choroidal Neovascularization Landscape Analysis by Major End-Users

    9 East China Choroidal Neovascularization Landscape Analysis

    • 9.1 East China Choroidal Neovascularization Landscape Analysis by Major Types

    • 9.2 East China Choroidal Neovascularization Landscape Analysis by Major End-Users

    10 Northeast China Choroidal Neovascularization Landscape Analysis

    • 10.1 Northeast China Choroidal Neovascularization Landscape Analysis by Major Types

    • 10.2 Northeast China Choroidal Neovascularization Landscape Analysis by Major End-Users

    11 Southwest China Choroidal Neovascularization Landscape Analysis

    • 11.1 Southwest China Choroidal Neovascularization Landscape Analysis by Major Types

    • 11.2 Southwest China Choroidal Neovascularization Landscape Analysis by Major End-Users

    12 Northwest China Choroidal Neovascularization Landscape Analysis

    • 12.1 Northwest China Choroidal Neovascularization Landscape Analysis by Major Types

    • 12.2 Northwest China Choroidal Neovascularization Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Pfizer Inc

      • 13.1.1 Pfizer Inc Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 F Hoffmann-La Roche Ltd

      • 13.2.1 F Hoffmann-La Roche Ltd Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Promedior Inc

      • 13.3.1 Promedior Inc Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Regeneron Pharmaceuticals Inc

      • 13.4.1 Regeneron Pharmaceuticals Inc Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 QLT Inc

      • 13.5.1 QLT Inc Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Sanwa Kagaku Kenkyusho Co Ltd

      • 13.6.1 Sanwa Kagaku Kenkyusho Co Ltd Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Valeant Pharmaceuticals International Inc

      • 13.7.1 Valeant Pharmaceuticals International Inc Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Bayer AG

      • 13.8.1 Bayer AG Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Novartis AG

      • 13.9.1 Novartis AG Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 Gilead Sciences Inc

      • 13.10.1 Gilead Sciences Inc Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Choroidal Neovascularization Market Size and Growth Rate of Intravenous from 2016 to 2027

    • Figure China Choroidal Neovascularization Market Size and Growth Rate of Intravitreal from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Choroidal Neovascularization Market Size and Growth Rate of Extreme Myopia from 2016 to 2027

    • Figure China Choroidal Neovascularization Market Size and Growth Rate of Malignant Myopic Degeneration from 2016 to 2027

    • Figure China Choroidal Neovascularization Market Size and Growth Rate of Age-related Developments from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Choroidal Neovascularization Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Choroidal Neovascularization Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Choroidal Neovascularization Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Choroidal Neovascularization Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Choroidal Neovascularization Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Choroidal Neovascularization Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Choroidal Neovascularization Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Choroidal Neovascularization Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Choroidal Neovascularization

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Choroidal Neovascularization by Different Types from 2016 to 2027

    • Table Consumption Share of Choroidal Neovascularization by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Intravenous

    • Figure Market Size and Growth Rate of Intravitreal

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Choroidal Neovascularization by Different End-Users from 2016 to 2027

    • Table Consumption Share of Choroidal Neovascularization by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Extreme Myopia

    • Figure Market Size and Growth Rate of Malignant Myopic Degeneration

    • Figure Market Size and Growth Rate of Age-related Developments

    • Table China Choroidal Neovascularization Production by Regions

    • Table China Choroidal Neovascularization Production Share by Regions

    • Figure China Choroidal Neovascularization Production Share by Regions in 2016

    • Figure China Choroidal Neovascularization Production Share by Regions in 2021

    • Figure China Choroidal Neovascularization Production Share by Regions in 2027

    • Table China Choroidal Neovascularization Consumption by Regions

    • Table China Choroidal Neovascularization Consumption Share by Regions

    • Figure China Choroidal Neovascularization Consumption Share by Regions in 2016

    • Figure China Choroidal Neovascularization Consumption Share by Regions in 2021

    • Figure China Choroidal Neovascularization Consumption Share by Regions in 2027

    • Table North China Choroidal Neovascularization Consumption by Types from 2016 to 2027

    • Table North China Choroidal Neovascularization Consumption Share by Types from 2016 to 2027

    • Figure North China Choroidal Neovascularization Consumption Share by Types in 2016

    • Figure North China Choroidal Neovascularization Consumption Share by Types in 2021

    • Figure North China Choroidal Neovascularization Consumption Share by Types in 2027

    • Table North China Choroidal Neovascularization Consumption by End-Users from 2016 to 2027

    • Table North China Choroidal Neovascularization Consumption Share by End-Users from 2016 to 2027

    • Figure North China Choroidal Neovascularization Consumption Share by End-Users in 2016

    • Figure North China Choroidal Neovascularization Consumption Share by End-Users in 2021

    • Figure North China Choroidal Neovascularization Consumption Share by End-Users in 2027

    • Table Central China Choroidal Neovascularization Consumption by Types from 2016 to 2027

    • Table Central China Choroidal Neovascularization Consumption Share by Types from 2016 to 2027

    • Figure Central China Choroidal Neovascularization Consumption Share by Types in 2016

    • Figure Central China Choroidal Neovascularization Consumption Share by Types in 2021

    • Figure Central China Choroidal Neovascularization Consumption Share by Types in 2027

    • Table Central China Choroidal Neovascularization Consumption by End-Users from 2016 to 2027

    • Table Central China Choroidal Neovascularization Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Choroidal Neovascularization Consumption Share by End-Users in 2016

    • Figure Central China Choroidal Neovascularization Consumption Share by End-Users in 2021

    • Figure Central China Choroidal Neovascularization Consumption Share by End-Users in 2027

    • Table South China Choroidal Neovascularization Consumption by Types from 2016 to 2027

    • Table South China Choroidal Neovascularization Consumption Share by Types from 2016 to 2027

    • Figure South China Choroidal Neovascularization Consumption Share by Types in 2016

    • Figure South China Choroidal Neovascularization Consumption Share by Types in 2021

    • Figure South China Choroidal Neovascularization Consumption Share by Types in 2027

    • Table South China Choroidal Neovascularization Consumption by End-Users from 2016 to 2027

    • Table South China Choroidal Neovascularization Consumption Share by End-Users from 2016 to 2027

    • Figure South China Choroidal Neovascularization Consumption Share by End-Users in 2016

    • Figure South China Choroidal Neovascularization Consumption Share by End-Users in 2021

    • Figure South China Choroidal Neovascularization Consumption Share by End-Users in 2027

    • Table East China Choroidal Neovascularization Consumption by Types from 2016 to 2027

    • Table East China Choroidal Neovascularization Consumption Share by Types from 2016 to 2027

    • Figure East China Choroidal Neovascularization Consumption Share by Types in 2016

    • Figure East China Choroidal Neovascularization Consumption Share by Types in 2021

    • Figure East China Choroidal Neovascularization Consumption Share by Types in 2027

    • Table East China Choroidal Neovascularization Consumption by End-Users from 2016 to 2027

    • Table East China Choroidal Neovascularization Consumption Share by End-Users from 2016 to 2027

    • Figure East China Choroidal Neovascularization Consumption Share by End-Users in 2016

    • Figure East China Choroidal Neovascularization Consumption Share by End-Users in 2021

    • Figure East China Choroidal Neovascularization Consumption Share by End-Users in 2027

    • Table Northeast China Choroidal Neovascularization Consumption by Types from 2016 to 2027

    • Table Northeast China Choroidal Neovascularization Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Choroidal Neovascularization Consumption Share by Types in 2016

    • Figure Northeast China Choroidal Neovascularization Consumption Share by Types in 2021

    • Figure Northeast China Choroidal Neovascularization Consumption Share by Types in 2027

    • Table Northeast China Choroidal Neovascularization Consumption by End-Users from 2016 to 2027

    • Table Northeast China Choroidal Neovascularization Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Choroidal Neovascularization Consumption Share by End-Users in 2016

    • Figure Northeast China Choroidal Neovascularization Consumption Share by End-Users in 2021

    • Figure Northeast China Choroidal Neovascularization Consumption Share by End-Users in 2027

    • Table Southwest China Choroidal Neovascularization Consumption by Types from 2016 to 2027

    • Table Southwest China Choroidal Neovascularization Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Choroidal Neovascularization Consumption Share by Types in 2016

    • Figure Southwest China Choroidal Neovascularization Consumption Share by Types in 2021

    • Figure Southwest China Choroidal Neovascularization Consumption Share by Types in 2027

    • Table Southwest China Choroidal Neovascularization Consumption by End-Users from 2016 to 2027

    • Table Southwest China Choroidal Neovascularization Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Choroidal Neovascularization Consumption Share by End-Users in 2016

    • Figure Southwest China Choroidal Neovascularization Consumption Share by End-Users in 2021

    • Figure Southwest China Choroidal Neovascularization Consumption Share by End-Users in 2027

    • Table Northwest China Choroidal Neovascularization Consumption by Types from 2016 to 2027

    • Table Northwest China Choroidal Neovascularization Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Choroidal Neovascularization Consumption Share by Types in 2016

    • Figure Northwest China Choroidal Neovascularization Consumption Share by Types in 2021

    • Figure Northwest China Choroidal Neovascularization Consumption Share by Types in 2027

    • Table Northwest China Choroidal Neovascularization Consumption by End-Users from 2016 to 2027

    • Table Northwest China Choroidal Neovascularization Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Choroidal Neovascularization Consumption Share by End-Users in 2016

    • Figure Northwest China Choroidal Neovascularization Consumption Share by End-Users in 2021

    • Figure Northwest China Choroidal Neovascularization Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Pfizer Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc

    • Figure Sales and Growth Rate Analysis of Pfizer Inc

    • Figure Revenue and Market Share Analysis of Pfizer Inc

    • Table Product and Service Introduction of Pfizer Inc

    • Table Company Profile and Development Status of F Hoffmann-La Roche Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche Ltd

    • Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche Ltd

    • Figure Revenue and Market Share Analysis of F Hoffmann-La Roche Ltd

    • Table Product and Service Introduction of F Hoffmann-La Roche Ltd

    • Table Company Profile and Development Status of Promedior Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Promedior Inc

    • Figure Sales and Growth Rate Analysis of Promedior Inc

    • Figure Revenue and Market Share Analysis of Promedior Inc

    • Table Product and Service Introduction of Promedior Inc

    • Table Company Profile and Development Status of Regeneron Pharmaceuticals Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Regeneron Pharmaceuticals Inc

    • Figure Sales and Growth Rate Analysis of Regeneron Pharmaceuticals Inc

    • Figure Revenue and Market Share Analysis of Regeneron Pharmaceuticals Inc

    • Table Product and Service Introduction of Regeneron Pharmaceuticals Inc

    • Table Company Profile and Development Status of QLT Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of QLT Inc

    • Figure Sales and Growth Rate Analysis of QLT Inc

    • Figure Revenue and Market Share Analysis of QLT Inc

    • Table Product and Service Introduction of QLT Inc

    • Table Company Profile and Development Status of Sanwa Kagaku Kenkyusho Co Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanwa Kagaku Kenkyusho Co Ltd

    • Figure Sales and Growth Rate Analysis of Sanwa Kagaku Kenkyusho Co Ltd

    • Figure Revenue and Market Share Analysis of Sanwa Kagaku Kenkyusho Co Ltd

    • Table Product and Service Introduction of Sanwa Kagaku Kenkyusho Co Ltd

    • Table Company Profile and Development Status of Valeant Pharmaceuticals International Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valeant Pharmaceuticals International Inc

    • Figure Sales and Growth Rate Analysis of Valeant Pharmaceuticals International Inc

    • Figure Revenue and Market Share Analysis of Valeant Pharmaceuticals International Inc

    • Table Product and Service Introduction of Valeant Pharmaceuticals International Inc

    • Table Company Profile and Development Status of Bayer AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer AG

    • Figure Sales and Growth Rate Analysis of Bayer AG

    • Figure Revenue and Market Share Analysis of Bayer AG

    • Table Product and Service Introduction of Bayer AG

    • Table Company Profile and Development Status of Novartis AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG

    • Figure Sales and Growth Rate Analysis of Novartis AG

    • Figure Revenue and Market Share Analysis of Novartis AG

    • Table Product and Service Introduction of Novartis AG

    • Table Company Profile and Development Status of Gilead Sciences Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gilead Sciences Inc

    • Figure Sales and Growth Rate Analysis of Gilead Sciences Inc

    • Figure Revenue and Market Share Analysis of Gilead Sciences Inc

    • Table Product and Service Introduction of Gilead Sciences Inc


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.